Literature DB >> 20621055

Epigenetic priming of a pre-B cell-specific enhancer through binding of Sox2 and Foxd3 at the ESC stage.

Daniel Liber1, Renae Domaschenz, Per-Henrik Holmqvist, Luca Mazzarella, Andrew Georgiou, Marion Leleu, Amanda G Fisher, Patricia A Labosky, Niall Dillon.   

Abstract

Modifications to the core histones are thought to contribute to ESC pluripotency by priming tissue-specific promoters and enhancers for later activation. However, it is unclear how these marks are targeted in ESCs and maintained during differentiation. Here, we show that the ESC factor Sox2 targets H3K4 methylation to monovalent and bivalent domains. In ESCs, Sox2 contributes to the formation of a monovalent mark at an enhancer in the pro/pre-B cell-specific lambda5-VpreB1 locus. Binding of Foxd3 suppresses intergenic transcription of the enhancer and surrounding sequences. In pro-B cells, enhancer activity is dependent on the Sox and Fox binding sites, and the enhancer is bound by Sox4, which is required for efficient expression of lambda5. Our results lead us to propose a factor relay model whereby ESC factors establish active epigenetic marks at tissue specific elements before being replaced by cell type-specific factors as cells differentiate. Copyright (c) 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20621055     DOI: 10.1016/j.stem.2010.05.020

Source DB:  PubMed          Journal:  Cell Stem Cell        ISSN: 1875-9777            Impact factor:   24.633


  46 in total

1.  Sequentially acting Sox transcription factors in neural lineage development.

Authors:  Maria Bergsland; Daniel Ramsköld; Cécile Zaouter; Susanne Klum; Rickard Sandberg; Jonas Muhr
Journal:  Genes Dev       Date:  2011-11-15       Impact factor: 11.361

2.  SOX after SOX: SOXession regulates neurogenesis.

Authors:  Michael Wegner
Journal:  Genes Dev       Date:  2011-12-01       Impact factor: 11.361

Review 3.  Enhancers: emerging roles in cell fate specification.

Authors:  Chin-Tong Ong; Victor G Corces
Journal:  EMBO Rep       Date:  2012-04-10       Impact factor: 8.807

4.  Loss of Foxd3 results in decreased β-cell proliferation and glucose intolerance during pregnancy.

Authors:  Jennifer L Plank; Audrey Y Frist; Alison W LeGrone; Mark A Magnuson; Patricia A Labosky
Journal:  Endocrinology       Date:  2011-09-27       Impact factor: 4.736

Review 5.  Chromatin "pre-pattern" and epigenetic modulation in the cell fate choice of liver over pancreas in the endoderm.

Authors:  Cheng-Ran Xu; Kenneth S Zaret
Journal:  Nucleus       Date:  2012-03-01       Impact factor: 4.197

Review 6.  Epigenomics: the science of no-longer-junk DNA. Why study it in chronic kidney disease?

Authors:  Yi-An Ko; Katalin Susztak
Journal:  Semin Nephrol       Date:  2013-07       Impact factor: 5.299

Review 7.  Human genetic variation within neural crest enhancers: molecular and phenotypic implications.

Authors:  Alvaro Rada-Iglesias; Sara L Prescott; Joanna Wysocka
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2013-05-06       Impact factor: 6.237

Review 8.  Functional and mechanistic diversity of distal transcription enhancers.

Authors:  Michael Bulger; Mark Groudine
Journal:  Cell       Date:  2011-02-04       Impact factor: 41.582

Review 9.  Eukaryotic enhancers: common features, regulation, and participation in diseases.

Authors:  Maksim Erokhin; Yegor Vassetzky; Pavel Georgiev; Darya Chetverina
Journal:  Cell Mol Life Sci       Date:  2015-02-26       Impact factor: 9.261

10.  Sequentially acting SOX proteins orchestrate astrocyte- and oligodendrocyte-specific gene expression.

Authors:  Susanne Klum; Cécile Zaouter; Zhanna Alekseenko; Åsa K Björklund; Daniel W Hagey; Johan Ericson; Jonas Muhr; Maria Bergsland
Journal:  EMBO Rep       Date:  2018-08-30       Impact factor: 8.807

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.